Abstract: User equipment includes a first antenna, a second antenna, a first transceiver coupled to the first antenna, a second transceiver coupled to the second antenna, and processing circuitry communicatively coupled to the first transceiver and the second transceiver. The first transceiver receives or transmits a first signal via the first antenna, and the second transceiver receives or transmits a second signal via the second antenna. The processing circuitry receives an indication that a signal characteristic of the first signal is less than a first threshold, and decreases power to the first antenna, the first receiver, or both, based on the signal characteristic of the first signal being less than the first threshold.

Abstract: The present invention relates to a modified bacterium with anti-tumor activity, which comprises an essential gene expression cassette under the control of a strictly hypoxia inducible promoter and is deficient in at least one gene involved in or regulating the endogenous anti-oxidative stress response pathway or a functional expression product thereof. The present invention also relates to a pharmaceutical composition comprising the modified bacterium and anti-tumor use thereof.

Abstract: Embodiments of the present disclosure provide an effect display method, apparatus and device, a storage medium, and a product. The method includes: acquiring an effect trigger instruction, the effect trigger instruction corresponding to a first image frame in a streaming media content of a live stream room, and the effect trigger instruction also corresponding to first effect information; in response to the effect trigger instruction, determining target effect information according to the first effect information and a target object in the first image frame; and sending the target effect information to a first client device associated with the live stream room, so that the first client device displays an effect corresponding to the target effect information.

Abstract: Embodiments of the present disclosure provide an effect display method, apparatus and device, a storage medium, and a product. The method includes: acquiring an effect trigger instruction, the effect trigger instruction corresponding to a first image frame in a streaming media content of a live stream room, and the effect trigger instruction also corresponding to first effect information; in response to the effect trigger instruction, determining target effect information according to the first effect information and a target object in the first image frame; and sending the target effect information to a first client device associated with the live stream room, so that the first client device displays an effect corresponding to the target effect information.

Abstract: User equipment includes a first antenna, a second antenna, a first transceiver coupled to the first antenna, a second transceiver coupled to the second antenna, and processing circuitry communicatively coupled to the first transceiver and the second transceiver. The first transceiver receives or transmits a first signal via the first antenna, and the second transceiver receives or transmits a second signal via the second antenna. The processing circuitry receives an indication that a signal characteristic of the first signal is less than a first threshold, and decreases power to the first antenna, the first receiver, or both, based on the signal characteristic of the first signal being less than the first threshold.

Abstract: A bacterial targeting vector and use thereof in tumor treatment, in particular, a bacterial targeting vector carrying a cytokine such as interleukin 6 and interleukin 10 or carrying a polynucleotide such as mRNA of the cytokine and use thereof in tumor treatment. An attenuated chassis bacterium capable of targeting solid tumors can be used as a delivery carrier of a tumor therapy molecule, and achieve expression and controllable release of a human/murine cytokine, thereby achieving anti-tumor effects.

Abstract: User equipment includes a first antenna, a second antenna, a first transceiver coupled to the first antenna, a second transceiver coupled to the second antenna, and processing circuitry communicatively coupled to the first transceiver and the second transceiver. The first transceiver receives or transmits a first signal via the first antenna, and the second transceiver receives or transmits a second signal via the second antenna. The processing circuitry receives an indication that a signal characteristic of the first signal is less than a first threshold, and decreases power to the first antenna, the first receiver, or both, based on the signal characteristic of the first signal being less than the first threshold.

Abstract: The present disclosure provides a vibrator driving method, including steps of: obtaining a preset vibration frequency and a resonant frequency of a target vibration motor; obtaining total harmonic distortion of the target vibration motor; obtaining at least one low distortion point of the target vibration motor according to the total harmonic distortion; obtaining a target vibration frequency according to a low distortion frequency of at least one low distortion point and the preset vibration frequency; driving the target vibration motor to vibrate according to the target vibration frequency. The present disclosure further provides a vibration driving system and a vibration driving equipment.

Abstract: A polynucleotide having promoter activity of a malate dehydrogenase gene (mdh gene), a transcription expression cassette, recombinant expression vector and recombinant host cell containing the polynucleotide having the promoter activity, a method for constructing a promoter mutant, a method for regulating the transcription of a target gene, a method for preparing a protein, and method for producing a target compound. The polynucleotide having the promoter activity is a mutant of an mdh gene promoter, and compared with a promoter of a wild-type mdh gene, the promoter activity of the mutant is significantly improved. After operably linking the mutant to a target gene, the expression efficiency of the target gene can be significantly improved, thereby effectively improving the yield and transformation rate of a target compound.

Abstract: A method for compensating a signal of a motor includes acquiring an original signal and nonlinear parameters of the motor; calculating a compensation signal for the original signal according to the acquired nonlinear parameters; and loading the calculated compensation signal into the motor to excite the motor to vibrate. An electronic apparatus and a storage medium are also provided. In this method, the original excitation signal is compensated for nonlinearity according to the nonlinear motor parameters, and is then used for exciting the motor. Therefore, the actual vibration effect can be closer to the expected effect as designed, which can bring more desirable tactility experience.

Abstract: The invention relates to a method for constructing an obligate anaerobic Salmonella strain, the obligate anaerobic Salmonella strain constructed by using said method, and the use thereof in tumor therapy.

Abstract: User equipment includes a first antenna, a second antenna, a first transceiver coupled to the first antenna, a second transceiver coupled to the second antenna, and processing circuitry communicatively coupled to the first transceiver and the second transceiver. The first transceiver receives or transmits a first signal via the first antenna, and the second transceiver receives or transmits a second signal via the second antenna. The processing circuitry receives an indication that a signal characteristic of the first signal is less than a first threshold, and decreases power to the first antenna, the first receiver, or both, based on the signal characteristic of the first signal being less than the first threshold.

Abstract: A user equipment (UE) is configured to operate in a non-standalone carrier aggregation (NSA CA) mode. The UE is also configured to determine an NSA CA bandwidth (BW) associated with bands being used for the NSA CA mode, determine a standalone carrier aggregation (SA CA) BW associated with bands being used for a SA CA mode after the UE is switched to the SA CA mode and determine, based on at least the NSA CA BW and the SA CA BW, for the UE to remain in the SA CA mode or switch to the NSA CA mode.

Abstract: Embodiments of the present disclosure provide an effect display method, apparatus and device, a storage medium, and a product. The method includes: acquiring an effect trigger instruction, the effect trigger instruction corresponding to a first image frame in a streaming media content of a live stream room, and the effect trigger instruction also corresponding to first effect information; in response to the effect trigger instruction, determining target effect information according to the first effect information and a target object in the first image frame; and sending the target effect information to a first client device associated with the live stream room, so that the first client device displays an effect corresponding to the target effect information.

Abstract: Provided are a polynucleotide having promoter activity and an application of the polynucleotide in producing an amino acid. Also disclosed are a transcription expression cassette, a recombinant expression vector, and a recombinant host cell which contain the polynucleotide, and a method for enhancing expression of a target gene, a method for preparing a protein, and a method for producing an amino acid. The polynucleotide having the promoter activity is a mutant of a polynucleotide having the sequence as shown in SEQ ID NO: 9. Compared with the polynucleotide having the sequence as shown in SEQ ID NO: 9, the promoter activity of the mutant is significantly enhanced, thereby promoting the stable and efficient expression of the target gene.

Abstract: Provided herein are populations of placental-derived natural killer cells comprising a cleavage resistant CD16. Also provided are methods of treating diseases, disorders or conditions in a human subject comprising administering to the subject an effective amount of a population of placental-derived natural killer cells comprising a cleavage resistant CD16 to the subject so as thereby to provide an effective treatment of the to the subject. The cells, such as CYNK cells, can be placental CD34+ cell-derived natural killer (NK) cells. The diseases, disorders or conditions include cancers such as multiple myeloma and lymphoma. The present invention also provides compositions comprising populations of placental-derived natural killer cells comprising a cleavage resistant CD16 for the treatment of a subject and methods of their use.

Abstract: Disclosed are a mutant of a pyruvate carboxylase gene promoter of Corynebacterium glutamicum and applications thereof. The mutant has improved promoter activity compared with a wild-type promoter, and can be used for enhancing expression of a target gene, for example, operably ligating the mutant to a pyruvate carboxylase gene enhances the expression intensity of the pyruvate carboxylase, thereby improving the production efficiency of amino acids of the strain.

Abstract: Provided are Corynebacterium glutamicum that produces L-lysine, a method for constructing the L-lysine producing strain, and a method for producing L-lysine from the strain. The lysine yield and glucose conversion of the L-lysine producing strain are improved, thereby reducing the production cost.

Abstract: Provided herein are methods of producing natural killer (NK) cells and/or ILC3 cells using a three-stage expansion and differentiation method with media comprising stem cell mobilizing factors. Also provided herein are methods of suppressing tumor cell proliferation using the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein, as well as methods of treating individuals having cancer or a viral infection, comprising administering the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein to an individual having the cancer or viral infection.

Abstract: The invention provides a motor nonlinear system modeling method including steps of: obtaining a chirp signal of a first frequency band, and a chirp signal of a second frequency band; exciting the motor by using the chirp signal; obtaining a higher harmonic frequency response of the first frequency band; exciting the motor by using the chirp signal of the second frequency band; obtaining a higher harmonic frequency response of the second frequency band; obtaining a higher harmonic frequency response by splicing the higher harmonic frequency response of the first frequency band and the higher harmonic frequency response of the second frequency band in the frequency domain. The higher harmonic frequency response of the working frequency of the motor is a nonlinear system model of the motor. By virtue of the method provided by the present invention, the accuracy of motor modeling is effectively improved.